What dementia medicines help Alzheimer’s dementia? 

Alzheimer dementia is the most common form of neurodegeneration, characterised by a progressive loss of memory and cognitive function. While there is currently no cure, several medications are used to manage symptoms and help individuals maintain their independence for a longer period. These treatments primarily work by regulating chemical messengers in the brain that are essential for learning and communication between nerve cells. 

The choice of medication often depends on the stage of the condition, ranging from mild memory impairment to more severe cognitive decline. In a clinical context, doctors focus on stabilising mental abilities and addressing behavioural changes that can occur as the disease progresses. This guide outlines the standard pharmacological options available and the emerging treatments that target the underlying causes of the condition. 

what we will discuss in this article 

• The function of cholinesterase inhibitors in early stages 

• How NMDA receptor antagonists protect brain cells 

• The benefits of combining different classes of medication 

• Private options for disease modifying amyloid therapies 

• Managing secondary symptoms like anxiety and aggression 

• Common side effects and monitoring requirements 

• emergency guidance for identifying signs of health deterioration 

Cholinesterase inhibitors 

Cholinesterase inhibitors are usually the first medications offered to people diagnosed with mild to moderate Alzheimer dementia. These drugs help increase the levels of acetylcholine, a chemical messenger in the brain that is vital for memory and concentration. 

There are three primary medicines in this group: 

• Donepezil: Often the first choice due to its once a day dosing and lower cost. 

• Rivastigmine: Available as a tablet or a skin patch, which is helpful for those who have trouble swallowing. 

• Galantamine: Typically used if other options are not tolerated. 

By slowing the breakdown of acetylcholine, these medications can temporarily improve or stabilise cognitive function. They do not stop the underlying damage to brain cells, but they can significantly enhance the quality of life during the early and middle stages of the disease. 

NMDA receptor antagonists 

As Alzheimer dementia progresses to the moderate or severe stages, a different class of medication known as NMDA receptor antagonists may be prescribed. The most common drug in this category is memantine. 

Memantine works by regulating the activity of glutamate, another important brain chemical. In a brain affected by Alzheimer, glutamate can be produced in excessive amounts, which overstimulates and eventually damages nerve cells. Memantine protects the brain by blocking the effects of this excess glutamate. This can help improve daily functioning and may reduce symptoms such as agitation and confusion in later stages. 

Combination therapy 

For individuals in the moderate to severe stages of Alzheimer, clinicians may recommend taking both a cholinesterase inhibitor and memantine at the same time. 

Recent clinical evidence suggests that this combination can be more effective than using either drug alone. The two types of medicine work in different ways to support brain function, which may lead to better management of both memory problems and behavioural disturbances. This dual approach is often considered when a person has already been taking donepezil, but their symptoms are becoming more difficult to manage. 

Disease modifying therapies 

A new group of medications called disease modifying therapies has recently become available for people in the very early stages of Alzheimer. These drugs, such as lecanemab and donanemab, are intravenous infusions that target and remove amyloid plaques from the brain. 

Unlike symptomatic treatments, these medicines aim to slow the actual progression of the disease. In clinical trials, they have been shown to reduce the rate of cognitive decline by approximately 27 to 36 percent. In the United Kingdom, these are currently only available through private healthcare providers as they have not yet been recommended for routine use on the National Health Service. 

Medication comparison table 

Medication Class	Example Drugs	Stage of Dementia	Primary Goal
Cholinesterase Inhibitors	Donepezil, Rivastigmine	Mild to Moderate	Boost memory and concentration
NMDA Antagonists	Memantine	Moderate to Severe	Protect cells from excess glutamate
Monoclonal Antibodies	Lecanemab, Donanemab	Early/Mild	Remove amyloid and slow progression
Antipsychotics	Risperidone	Severe	Manage acute aggression or distress

Summary 

Medicines for Alzheimer dementia focus on enhancing the communication between healthy neurons and protecting them from further damage. From the early use of cholinesterase inhibitors to the later addition of memantine, these treatments provide essential support for mental abilities. While the introduction of amyloid targeting drugs offers a new way to slow the disease, symptomatic management remains the cornerstone of care. Working closely with a medical team ensures that the most appropriate medications are selected and monitored throughout the journey. 

emergency guidance 

Acute medical or behavioural changes in a person with dementia require immediate clinical attention. Call 999 or seek urgent help if you notice a sudden onset of facial drooping, arm weakness, or slurred speech, as these are signs of a stroke. Additionally, if the person becomes profoundly and suddenly confused (delirium), it may be caused by a severe infection like a urinary tract infection. Seek emergency care if there is a suspected adverse reaction to medication, such as extreme muscle stiffness, high fever, or a significant fall. Any sudden inability to swallow is also a medical emergency that carries a high risk of choking. 

Authority Snapshot 

Dr. Rebecca Fernandez is a UK trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence based approaches such as CBT, ACT, and mindfulness based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well being.